Phase I and pharmacokinetic study of a novel mitomycin C analog KW-2149.
Dirix L, Catimel G, Koier I, Provè A, Schrijvers D, Joossens E, De Bruijn E, Ardiet C, Evene E, Dumortier A, et al.
Dirix L, et al.
Anticancer Drugs. 1995 Feb;6(1):53-63. doi: 10.1097/00001813-199502000-00006.
Anticancer Drugs. 1995.
PMID: 7756684
Clinical Trial.